The Inclusion of Timolol and Lisinopril in Calcium Phosphate Particles Covered by Chitosan: Application in Ophthalmology
- Авторлар: Nikolskaya I.I.1, Beznos O.V.2, Eltsov A.I.1, Gachok I.V.1, Chesnokova N.B.2, Varlamov V.P.3, Kost O.A.1
-
Мекемелер:
- Department of Chemistry
- Helmholtz Moscow Research Institute of Eye Diseases
- Federal Research Center “Fundamentals of Biotechnology,”
- Шығарылым: Том 73, № 2 (2018)
- Беттер: 85-89
- Бөлім: Article
- URL: https://bakhtiniada.ru/0027-1314/article/view/163638
- DOI: https://doi.org/10.3103/S0027131418020116
- ID: 163638
Дәйексөз келтіру
Аннотация
Chitosan-covered calcium phosphate nanoparticles with the mean dynamic radii of 30 to 130 nm and ζ-potential of +22 ± 4 mV containing timolol and lisinopril are prepared and characterized. These particles are formed by the amorphous phase represented by amorphous calcium phosphate Cax(PO4)y · zH2O and the crystalline phase represented by hydrated calcium hydrophoshate (brushite) CaHPO4 · 2H2O. The experiments in vivo demonstrated that the inclusion of timolol into calcium phosphate particles covered with chitosan substantially prolonged its effect on the intraocular pressure.
Негізгі сөздер
Авторлар туралы
I. Nikolskaya
Department of Chemistry
Email: olga.a.kost@gmail.com
Ресей, Moscow, 119991
O. Beznos
Helmholtz Moscow Research Institute of Eye Diseases
Email: olga.a.kost@gmail.com
Ресей, Moscow, 105062
A. Eltsov
Department of Chemistry
Email: olga.a.kost@gmail.com
Ресей, Moscow, 119991
I. Gachok
Department of Chemistry
Email: olga.a.kost@gmail.com
Ресей, Moscow, 119991
N. Chesnokova
Helmholtz Moscow Research Institute of Eye Diseases
Email: olga.a.kost@gmail.com
Ресей, Moscow, 105062
V. Varlamov
Federal Research Center “Fundamentals of Biotechnology,”
Email: olga.a.kost@gmail.com
Ресей, Moscow, 119071
O. Kost
Department of Chemistry
Хат алмасуға жауапты Автор.
Email: olga.a.kost@gmail.com
Ресей, Moscow, 119991
Қосымша файлдар
